CRISPR THERAPEUTICS AG

Ticker: CRSP CUSIP: H17182108 Class: NAMEN AKT

BALYASNY ASSET MANAGEMENT L.P.'s Holding History (CIK: 0001218710)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 21,202 Value ($000) $1,112 Avg Close $59.89 Range $48.02 - $78.48
Q1 2025
Shares 83,467 Value ($000) $2,840 Avg Close $42.39 Range $32.96 - $55.88
Q4 2024
Shares 893,935 Value ($000) $35,185 Avg Close $47.22 Range $38.20 - $59.07
Q3 2024
Shares 623,650 Value ($000) $29,299 Avg Close $50.74 Range $43.42 - $63.68
Q2 2024
Shares 90,664 Value ($000) $4,897 Avg Close $57.84 Range $51.02 - $68.39
Q4 2022
Shares 64,580 Value ($000) $2,625 Avg Close $53.05 Range $38.94 - $66.31
Q3 2022
Shares 22,562 Value ($000) $1,475 Avg Close $72.47 Range $60.41 - $86.95
Q1 2022
Shares 7,016 Value ($000) $440 Avg Close $62.79 Range $50.54 - $79.40
Q4 2021
Shares 5,847 Value ($000) $443 Avg Close $87.36 Range $67.15 - $112.39
Q3 2021
Shares 10,688 Value ($000) $1,196 Avg Close $125.59 Range $109.63 - $163.00
Q4 2020
Shares 3,418 Value ($000) $523 Avg Close $118.20 Range $79.31 - $181.42
Q3 2020
Shares 99,802 Value ($000) $8,347 Avg Close $88.70 Range $74.00 - $105.12
Q2 2020
Shares 5,963 Value ($000) $438 Avg Close $58.47 Range $38.10 - $79.92
Q2 2019
Shares 109,657 Value ($000) $5,165 Avg Close $39.97 Range $34.91 - $48.30